Alabama · 2026 Regular Session · Bill

HB 127: Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

In committee Last action January 13, 2026: Read for the first time and referred to the House Committee on Health

Plain-language summary

HB 127 is a bill introduced in the Alabama House on January 7, 2026. According to its official title, it concerns: Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine. Primary sponsor: Chip Brown (Republican). Most recent recorded action (January 13, 2026): Read for the first time and referred to the House Committee on Health.

Sponsors

Primary sponsor: Chip Brown (Republican).